Related Experiment Video
Updated: Jan 28, 2026
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
The Impact of Molecular Testing for Pathogens of Community-Acquired Pneumonia on Antibiotic Utilization
Joshua Rezkalla1, Susan E Hoover2, Jennifer Hsu2
1Department of Medicine-Pediatrics, University of California Los Angeles, Los Angeles, California.
Abstract:
Community-acquired pneumonia (CAP) is a common and costly problem in U.S. healthcare. A major challenge in development of targeted treatment strategies has been limitations in diagnostic testing to confirm specific pathogens, including viruses. The recent and widespread use of multiplex polymerase chain reaction (mPCR) to identify pathogens has created an opportunity to improve diagnostic testing and subsequent antibiotic stewardship. We performed a retrospective cohort study examining 233 inpatients with pneumonia of which 70 patients underwent testing with mPCR. A specific pathogen was identified by mPCR in 24 percent of these patients and there was a statistically significant decrease in antibiotic use between patients who tested negative (average 8.3 days of antibiotics) versus patients who tested positive (average 4.9 days of antibiotics). This highlights the potential utility of mPCR implementation as an antibiotic stewardship strategy.
Insights
Multiplex polymerase chain reaction (mPCR) testing for community-acquired pneumonia (CAP) can improve antibiotic stewardship. Identifying specific pathogens via mPCR significantly reduced antibiotic duration in hospitalized patients.
Area of Science:
- Medical Diagnostics
- Infectious Diseases
- Public Health
Background:
- Community-acquired pneumonia (CAP) presents a significant healthcare burden in the U.S.
- Limited diagnostic capabilities hinder targeted treatment strategies for CAP, particularly for viral pathogens.
- The increasing availability of multiplex polymerase chain reaction (mPCR) offers a novel approach to pathogen identification.
Purpose of the Study:
- To evaluate the impact of mPCR testing on antibiotic use in hospitalized patients with CAP.
- To assess the utility of mPCR as a tool for enhancing antibiotic stewardship.
Main Methods:
- A retrospective cohort study was conducted involving 233 inpatients diagnosed with pneumonia.
- Seventy patients underwent diagnostic testing using mPCR to identify specific pathogens.
- Antibiotic usage duration was compared between patients who tested positive and negative for pathogens via mPCR.
Main Results:
- mPCR identified a specific pathogen in 24% of the tested patients.
- Patients testing positive for a pathogen with mPCR received significantly fewer days of antibiotics (average 4.9 days) compared to those testing negative (average 8.3 days).
- A statistically significant reduction in antibiotic use was observed in patients with pathogen identification.
Conclusions:
- Implementation of mPCR testing demonstrates potential as an effective antibiotic stewardship strategy for CAP.
- Improved pathogen detection through mPCR can lead to more judicious antibiotic prescribing.
- mPCR offers a valuable tool for optimizing CAP management and combating antimicrobial resistance.
Related Concept Videos
00:30What are Populations and Communities?
00:57Antibiotic Selection
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia II: Pathophysiology
02:00Molecular Models
01:19Impact of Groups on Groups